Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness
Bluejay Diagnostics completed establishment of a Symphony cartridge manufacturing site at SanyoSeiko in Japan, fulfilling a contractual milestone under its amended Toray license agreement ahead of the October 23, 2026 deadline. The company is building complementary manufacturing capacity with SanyoSeiko in Japan and ALURIS Sciences in the U.S. to add redundancy and supply-chain resilience.
Key figures
- Drug Name
- Symphony IL-6 Test
- Contractual deadline
- 2026-10-23
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.